• Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Geriatrics
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Oncology
  • Nephrology
  • Neurology
  • Pulmonology

The "Sweet Spot" in Type 2 Diabetes Management

News
Slideshow

The new "sweet spot" in diabetes management is the interdisciplinary approach that is essential to treating all aspects of the disease. New diabetes medications also hit that spot.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Related Content
Semaglutide Linked to Reduced Risk for MACE Months Before Weight Loss Begins: Post Hoc Analysis / image credit Jorge Plutzky, MD, Brigham and Women's Hospital

Semaglutide Linked to Reduced Risk for MACE Months Before Weight Loss Begins: Post Hoc Analysis

Grace Halsey
May 14th 2025
Article

Semaglutide was associated with a significant reduction in risk for major adverse cardiovascular events after just 3 months of treatment in a population with established CVD.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Sydney Jennings
August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Investigational GPR119 Agonist Shows Dual Hepatoprotective and Glycemic Benefits in MASH Patients / image credit ©Wowow/stock.adobe.com

Investigational GPR119 Agonist Shows Dual Hepatoprotective and Glycemic Benefits in MASH Patients

Grace Halsey
May 7th 2025
Article

EASL 2025. DA-1241 significantly reduced plasma ALT levels, improved systemic inflammatory and fibrosis biomarkers, according to drug developer MetaVia.

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Adolescent Hyperglycemia, Insulin Resistance Drive Early Cardiac Structural Changes / image credit Andrew Agbaje, MD, MPH, PhD Courtesy of University of Eastern Finland

Adolescent Hyperglycemia, Insulin Resistance Drive Early Cardiac Structural Changes, Novel Cohort Study Finds

Grace Halsey
May 2nd 2025
Article

Persistent hyperglycemia between ages 17 and 24 tripled the risk of left ventricular hypertrophy and did so 5 times faster among young women, a new study found.

High Blood Pressure Advisory in EHR Improves Hypertension Diagnosis, Control Across a Primary Care Network / image credit Meeko Media

High Blood Pressure Advisory in EHR Improves Hypertension Diagnosis, Control Across a Primary Care Network

Grace Halsey
April 30th 2025
Article

An EHR advisory that combined alerts to medical assistants with escalation to clinicians increased likelihood of hypertension control by a mean 18% per month.

© 2025 MJH Life Sciences

All rights reserved.